Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where F. Menasci is active.

Publication


Featured researches published by F. Menasci.


World Journal of Gastrointestinal Pathophysiology | 2014

“Mucosal healing” in ulcerative colitis:Between clinical evidence and market suggestion

Cristiano Pagnini; F. Menasci; Stefano Festa; G. Rizzatti; Gianfranco Delle Fave

In recent decades, the prominent role of endoscopy in the management of ulcerative colitis (UC) has been translated into the concept of mucosal healing (MH) as a fundamental therapeutic end-point. This is partially the consequence of growing evidence of a positive prognostic role of MH on the disease course and partially due to market cues indicating a higher rate of MH in patients treated by novel potent biologic agents. The aim of the present review is to clarify the current knowledge of MH in UC, analyzing the definition, the putative prognostic role and the association of MH with the current drugs used to treat UC patients. Because solid data about the management of UC patients based solely on the healing of the mucosa are not yet available, a tailored approach for individual patients thatconsiders the natural history of UC and the presence of prognostic indicators of aggressive disease is desirable. Consequently, unnecessary examinations and treatment would be avoided and restricted to UC patients who require the maximum amount of effort to affect the disease course in the short and long term.


Journal of Crohns & Colitis | 2015

Disease Extension Matters in Endoscopic Scores: UCEIS Calculated as a Sum of the Single Colonic Segments Performed Better than Regular UCEIS in Outpatients with Ulcerative Colitis

F. Menasci; C. Pagnini; Emilio Di Giulio

We have read with great interest the article by Corte et al .1 Indeed, the Ulcerative Colitis Endoscopic Index of Severity [UCEIS] provides an accurate evaluation of the mucosal appearance together with high intra- and inter-observer agreement.2,3 Nonetheless, it considers just the more inflamed colonic segment, not including the disease extension. This could from one side allow the calculation of the score even from a rectum-sigmoidoscopy, thus avoiding complete colonoscopy that may be contraindicated in particular settings such as acute severe ulcerative colitis [UC]. From the other side, this may represent a potential limitation, in particular in outpatients where total colonoscopy may be the most appropriate examination.4 We retrospectively analysed data of 80 UC outpatients, between 2009 and 2013, at S. Andrea Hospital in Rome, Italy. We included patients who had, within a 1-month period, …


Digestive and Liver Disease | 2016

Endoscopic scores for inflammatory bowel disease in the era of 'mucosal healing': Old problem, new perspectives

C. Pagnini; F. Menasci; F. Desideri; Vito D. Corleto; Gianfranco Delle Fave; Emilio Di Giulio


Current Clinical Pharmacology | 2014

Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question

Giovanna Margagnoni; Cristiano Pagnini; F. Menasci; Stefano Festa; Gianfranco Delle Fave


European Review for Medical and Pharmacological Sciences | 2015

Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: Correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results

C. Pagnini; F. Menasci; Stefano Festa; G. Rizzatti; Vito D. Corleto; M. M. Delle Fave; G. D'Ambra; E. Di Giulio; G. Delle Fave


Digestive and Liver Disease | 2017

OC.08.3: A Prospective, Monocentric, Randomized Study Evaluating 6 Month Vs. 1 Year Follow-Up Visit for Ulcerative Colitis Patients in Stable Remission: Clinical, Economic and Compliance Evaluation

C. Pagnini; F. Menasci; F. Desideri; A. Sanna; Vito D. Corleto; G. Delle Fave


Digestive and Liver Disease | 2016

P.14.13 Endoscopic Activity Evaluation in Ulcerative Colitis: Still an Unsolved Issue

C. Pagnini; Vito D. Corleto; F. Menasci; F. Desideri; G. Delle Fave; E. Di Giulio


Digestive and Liver Disease | 2016

P.14.15 EFFICACY AND SAFETY OF INFLIXIMAB AND ADALIMUMAB IN CROHN'S DISEASE PATIENTS IN A SINGLE IBD CENTER: A RETROSPECTIVE REAL-LIFE STUDY

F. Desideri; C. Pagnini; F. Menasci; Marina Capasso; Vito D. Corleto; G. Delle Fave


Digestive and Liver Disease | 2016

P.14.6 Prevalence and Clinical Significance of Hypergammaglobulinemia in Inflammatory Bowel Disease Patients: A Retrospective Cross-Sectional Study

F. Menasci; C. Pagnini; F. Desideri; A. Sanna; G. Delle Fave


Gastroenterology | 2015

1049 Mucosal Adhesion and Anti-Inflammatory Effect of Lactobacillus rhamnosus GG in Human Colonic Mucosa Evaluated In Vivo and in an Experimental Ex Vivo Model: A Proof the Concept Study

Cristiano Pagnini; Michela Martorelli; Claudio Lanini; G. Rizzatti; Vito D. Corleto; F. Menasci; S. Angeletti; Emilio Di Giulio; Gianfranco Delle Fave

Collaboration


Dive into the F. Menasci's collaboration.

Top Co-Authors

Avatar

C. Pagnini

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Vito D. Corleto

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

G. Delle Fave

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

G. Rizzatti

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Stefano Festa

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

E. Di Giulio

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

F. Desideri

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emilio Di Giulio

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

G. D'Ambra

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge